The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.
| Autor: | Kammer, Michael N.1, Deppen, Stephen A.2,3, Antic, Sanja1, Rahman, S. M. Jamshedur1, Eisenberg, Rosana4, Maldonado, Fabien1, Aldrich, Melinda C.2,5,6, Sandler, Kim L.7, Landman, Bennett8, Massion, Pierre P.1,3,6, Grogan, Eric L.2,3 eric.grogan@vumc.org |
|---|---|
| Zdroj: | Cancer Biomarkers. 2022, Vol. 33 Issue 4, p449-465. 17p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|